相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。mGlu2/3 receptor antagonism: A mechanism to induce rapid antidepressant effects without ketamine-associated side-effects
Jeffrey M. Witkin
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2020)
Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies
Thu Ha Pham et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Overcoming Resistance to Selective Serotonin Reuptake Inhibitors: Targeting Serotonin, Serotonin-1A Receptors and Adult Neuroplasticity
Faranak Vahid-Ansari et al.
FRONTIERS IN NEUROSCIENCE (2019)
The influence of ketamine on drug discovery in depression
Christoph Kraus et al.
DRUG DISCOVERY TODAY (2019)
Brain structure alterations in depression: Psychoradiological evidence
Fei-Fei Zhang et al.
CNS NEUROSCIENCE & THERAPEUTICS (2018)
Association of Catechol-O-methyltransferase (COMT Val158Met) with future risk of cardiovascular disease in depressed individuals - a Swedish population-based cohort study
Aysha Almas et al.
BMC MEDICAL GENETICS (2018)
Decreased resting state metabolic activity in frontopolar and parietal brain regions is associated with suicide plans in depressed individuals
Kees van Heeringen et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2017)
Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism
Lily R. Aleksandrova et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2017)
The Effect of Serotonin-Targeting Antidepressants on Neurogenesis and Neuronal Maturation of the Hippocampus Mediated via 5-HT1A and 5-HT4 Receptors
Eri Segi-Nishida
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
This work was supported by JSPS KAKENHI Grant Number 25460096 (to E.S-N), 25116525 (to KK),and 15H01296 (to KK); The Naito Foundation (to E.S-N); the foundation for Pharmaceutical Sciences (to E. S-N); Brain Science Foundation (to KK); Takeda Science Foundation (to KK) and Japan Science and Technology Agency, Core Research for Evolutional Science and Technology (to K.K and HS). Rapid and stable changes in maturation-related phenotypes of the adult hippocampal neurons by electroconvulsive treatment
Yuki Imoto et al.
MOLECULAR BRAIN (2017)
The Energy Metabolism Dysfunction in Psychiatric Disorders Postmortem Brains: Focus on Proteomic Evidence
Giuliana S. Zuccoli et al.
FRONTIERS IN NEUROSCIENCE (2017)
Avarol derivatives as competitive AChE inhibitors, non hepatotoxic and neuroprotective agents for Alzheimer's disease
Giuseppina Tommonaro et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Vortioxetine: a New Treatment for Major Depressive Disorder
K. Ryan Connolly et al.
EXPERT OPINION ON PHARMACOTHERAPY (2016)
The absence of 5-HT4 receptors modulates depression- and anxiety-like responses and influences the response of fluoxetine in olfactory bulbectomised mice: Adaptive changes in hippocampal neuroplasticity markers and 5-HT1A autoreceptor
J. Amigo et al.
NEUROPHARMACOLOGY (2016)
The role of glutamatergic, GABA-ergic, and cholinergic receptors in depression and antidepressant-like effect
Karolina Pytka et al.
PHARMACOLOGICAL REPORTS (2016)
What Do We Really Know About 5-HT1A Receptor Signaling in Neuronal Cells?
Paulina S. Rojas et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2016)
Long-term antidepressant use: patient perspectives of benefits and adverse effects
Claire Cartwright et al.
PATIENT PREFERENCE AND ADHERENCE (2016)
Molecular Neurobiology and Promising New Treatment in Depression
Sang Won Jeon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Brain Structural Effects of Antidepressant Treatment in Major Depression
Nicola Dusi et al.
CURRENT NEUROPHARMACOLOGY (2015)
5-HT1A receptors on mature dentate gyrus granule cells are critical for the antidepressant response
Benjamin Adam Samuels et al.
NATURE NEUROSCIENCE (2015)
Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data
Connie Sanchez et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Role of the 5-HT4 receptor in chronic fluoxetine treatment-induced neurogenic activity and granule cell dematuration in the dentate gyrus
Yuki Imoto et al.
MOLECULAR BRAIN (2015)
NEUROBIOLOGY OF STRESS, DEPRESSION, AND RAPID ACTING ANTIDEPRESSANTS: REMODELING SYNAPTIC CONNECTIONS
Ronald S. Duman
DEPRESSION AND ANXIETY (2014)
Profiles of psychiatric symptoms among amphetamine type stimulant and ketamine using inpatients in Wuhan, China
Yao Zhang et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2014)
THE ROLE OF D2-AUTORECEPTORS IN REGULATING DOPAMINE NEURON ACTIVITY AND TRANSMISSION
C. P. Ford
NEUROSCIENCE (2014)
Frontal-Subcortical Volumetric Deficits in Single Episode, Medication-Naive Depressed Patients and the Effects of 8 Weeks Fluoxetine Treatment: A VBM-DARTEL Study
Lingtao Kong et al.
PLOS ONE (2014)
ANTIDEPRESSANT EFFECTS OF AN INVERSE AGONIST SELECTIVE FOR α5 GABA-A RECEPTORS IN THE RAT FORCED SWIM TEST
Janko Samardzic et al.
ACTA VETERINARIA-BEOGRAD (2014)
Antidepressants and the Placebo Effect
Irving Kirsch
ZEITSCHRIFT FUR PSYCHOLOGIE-JOURNAL OF PSYCHOLOGY (2014)
The Epidemiology of Depression Across Cultures
Ronald C. Kessler et al.
ANNUAL REVIEW OF PUBLIC HEALTH, VOL 34 (2013)
Pharmacokinetic Drug Interactions Involving Vortioxetine (Lu AA21004), a Multimodal Antidepressant
Grace Chen et al.
CLINICAL DRUG INVESTIGATION (2013)
Lu AA21004, a novel multimodal antidepressant, produces regionally selective increases of multiple neurotransmitters-A rat microdialysis and electrophysiology study
Alan L. Pehrson et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)
Antidepressant effects of sertraline associated with volume increases in dorsolateral prefrontal cortex
Ryan Smith et al.
JOURNAL OF AFFECTIVE DISORDERS (2013)
Modafinil Augmentation Therapy in Unipolar and Bipolar Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Alexander J. Goss et al.
JOURNAL OF CLINICAL PSYCHIATRY (2013)
Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice
Jean-Philippe Guilloux et al.
NEUROPHARMACOLOGY (2013)
Fluoxetine-Induced Cortical Adult Neurogenesis
Koji Ohira et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Deficiency of Schnurri-2, an MHC Enhancer Binding Protein, Induces Mild Chronic Inflammation in the Brain and Confers Molecular, Neuronal, and Behavioral Phenotypes Related to Schizophrenia
Keizo Takao et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Hippocampal Granule Neuron Number and Dentate Gyrus Volume in Antidepressant-Treated and Untreated Major Depression
Maura Boldrini et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Corticosterone Facilitates Fluoxetine-Induced Neuronal Plasticity in the Hippocampus
Katsunori Kobayashi et al.
PLOS ONE (2013)
Treatment Course With Antidepressant Therapy in Late-Life Depression
Yvette I. Sheline et al.
AMERICAN JOURNAL OF PSYCHIATRY (2012)
Role of vascular endothelial growth factor in adult hippocampal neurogenesis: Implications for the pathophysiology and treatment of depression
Neil M. Fournier et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
The neurobiology of depression
Eleni Palazidou
BRITISH MEDICAL BULLETIN (2012)
Effects of the multimodal antidepressant Lu AA21004 on rat synaptic and cellular hippocampal plasticity and memory recognition
N. Haddjeri et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2012)
G protein-coupled receptors in the hypothalamic paraventricular and supraoptic nuclei - serpentine gateways to neuroendocrine homeostasis
Georgina G. J. Hazell et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2012)
A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior
M. Carlen et al.
MOLECULAR PSYCHIATRY (2012)
Serotonin receptor expression along the dorsal-ventral axis of mouse hippocampus
Kenji F. Tanaka et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)
Synaptic Dysfunction in Depression: Potential Therapeutic Targets
Ronald S. Duman et al.
SCIENCE (2012)
Etiology of Depression: Genetic and Environmental Factors
Radu V. Saveanu et al.
PSYCHIATRIC CLINICS OF NORTH AMERICA (2012)
Pharmacological Effects of Lu AA21004: A Novel Multimodal Compound for the Treatment of Major Depressive Disorder
A. Mork et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
The GABA(B) receptor as a target for antidepressant drug action
Subroto Ghose et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Neurotrophins Role in Depression Neurobiology: A Review of Basic and Clinical Evidence
Fani L. Neto et al.
Current Neuropharmacology (2011)
Brain effects of antidepressants in major depression: A meta-analysis of emotional processing studies
Pauline Delaveau et al.
JOURNAL OF AFFECTIVE DISORDERS (2011)
Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice
E. Beurel et al.
MOLECULAR PSYCHIATRY (2011)
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
Jean-Martin Beaulieu et al.
PHARMACOLOGICAL REVIEWS (2011)
Rapid decrease in depressive symptoms with an N-methyl-D-aspartate antagonist in ECT-resistant major depression
Lobna Ibrahim et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
The role of serotonin receptor subtypes in treating depression: a review of animal studies
Gregory V. Carr et al.
PSYCHOPHARMACOLOGY (2011)
Glycogen synthase kinase-3 in the etiology and treatment of mood disorders
Richard Scott Jope
FRONTIERS IN MOLECULAR NEUROSCIENCE (2011)
Relationship Between Amygdala Responses to Masked Faces and Mood State and Treatment in Major Depressive Disorder
Teresa A. Victor et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Reduced signal transduction by 5-HT4 receptors after long-term venlafaxine treatment in rats
R. Vidal et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Fluoxetine treatment induces dose dependent alterations in depression associated behavior and neural plasticity in female mice
Georgia E. Hodes et al.
NEUROSCIENCE LETTERS (2010)
Tryptophan Hydroxylase as Novel Target for the Treatment of Depressive Disorders
Susann Matthes et al.
PHARMACOLOGY (2010)
Reversal of hippocampal neuronal maturation by serotonergic antidepressants
Katsunori Kobayashi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Nanxin Li et al.
SCIENCE (2010)
Genetics of childhood and adolescent depression: insights into etiological heterogeneity and challenges for future genomic research
Frances Rice
GENOME MEDICINE (2010)
Oppositional effects of serotonin receptors 5-HT1a, 2, and 2c in the regulation of adult hippocampal neurogenesis
Friederike Klempin et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2010)
Long-term treatment with fluoxetine induces desensitization of 5-HT4 receptor-dependent signalling and functionality in rat brain
Rebeca Vidal et al.
JOURNAL OF NEUROCHEMISTRY (2009)
The brain 5-HT4 receptor binding is down-regulated in the Flinders Sensitive Line depression model and in response to paroxetine administration
Cecilie L. Licht et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Positive AMPA Receptor Modulation Rapidly Stimulates BDNF Release and Increases Dendritic mRNA Translation
Hussam Jourdi et al.
JOURNAL OF NEUROSCIENCE (2009)
Prognostic and Diagnostic Potential of the Structural Neuroanatomy of Depression
Sergi G. Costafreda et al.
PLOS ONE (2009)
Antidepressant properties of the 5-HT4 receptor partial agonist, SL65.0155: Behavioral and neurochemical studies in rats
Alessandra Tamburella et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Increased subgenual prefrontal cortex size in remitted patients with major depressive disorder
Kaan Yucel et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2009)
Cellular mechanisms underlying the antidepressant effects of ketamine:: Role of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors
Sungho Maeng et al.
BIOLOGICAL PSYCHIATRY (2008)
Synthesis and Biological Activities of Thio-avarol Derivatives
Boris Pejin et al.
JOURNAL OF NATURAL PRODUCTS (2008)
Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells
Jing-Wen Wang et al.
JOURNAL OF NEUROSCIENCE (2008)
Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders
Nobuyuki Yamasaki et al.
Molecular Brain (2008)
St John's wort for major depression
Klaus Linde et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2008)
Anorexia induced by activation of serotonin 5-HT4 receptors is mediated by increases in CART in the nucleus accumbens
Alexandra Jean et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Serotonin4 (5-HT4) receptor Agonists are putative antidepressants with a rapid onset of action
Guillaume Lucas et al.
NEURON (2007)
Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment
Chi-Hua Chen et al.
BIOLOGICAL PSYCHIATRY (2007)
The chemical imbalance explanation for depression: Origins, lay endorsement, and clinical implications
Christopher M. France et al.
PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE (2007)
Reduced 5-HT1A- and GABAB receptor function in dorsal raphe neurons upon chronic fluoxetine treatment of socially stressed rats
L. N. Cornelisse et al.
JOURNAL OF NEUROPHYSIOLOGY (2007)
Urinary epidermal and insulin-like growth factor excretion in autistic children
B. Anlar et al.
NEUROPEDIATRICS (2007)
Antidepressant-like effects of agomelatine (S 20098) in the learned helplessness model
Valerie Bertaina-Anglade et al.
BEHAVIOURAL PHARMACOLOGY (2006)
Placebo-controlled trial of agomelatine in the treatment of major depressive disorder
SH Kennedy et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2006)
Clinical efficacy of agomelatine in depression: the evidence
JA Den Boer et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2006)
Coping predicts depression and disability in heart transplant candidates
EJ Burker et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2005)
Antidepressant exposure may protect against decrement in frontal gray matter volumes in geriatric depression
H Lavretsky et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Mechanisms of action of antidepressants: from neurotransmitter systems to signaling pathways
C Taylor et al.
CELLULAR SIGNALLING (2005)
Modifications of 5-HT4 receptor expression in rat brain during memory consolidation
L Manuel-Apolinar et al.
BRAIN RESEARCH (2005)
Serotonin 5-HT4 receptors and their mRNAs in rat and guinea pig brain:: Distribution and effects of neurotoxic lesions
MT Vilaró et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2005)
Frontocortical 5-HT4 receptors exert positive feedback on serotonergic activity:: Viral transfections, subacute and chronic treatments with 5-HT4 agonists
G Lucas et al.
BIOLOGICAL PSYCHIATRY (2005)
Strategies for productring faster acting antidepressants
A Adell et al.
DRUG DISCOVERY TODAY (2005)
Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties:: role of 5-HT2C receptor blockade
MJ Millan et al.
PSYCHOPHARMACOLOGY (2005)
Differential effects of the novel antidepressant agomelatine (S 20098) versus fluoxetine on 5-HT1A receptors in the rat brain
N Hanoun et al.
NEUROPHARMACOLOGY (2004)
Attenuation of the neural response to sad faces in major depression by antidepressant treatment - A prospective, event-related functional magnetic resonance imaging study
CHY Fu et al.
ARCHIVES OF GENERAL PSYCHIATRY (2004)
Neuroplasticity: from MRI to depressive symptoms
P Fossati et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2004)
Review article: serotonin receptors and transporters - roles in normal and abnormal gastrointestinal motility
MD Gershon
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Altered 5-HT2A and 5-HT4 postsynaptic receptors and their intracellular signalling systems IP3 and cAMP in brains from depressed violent suicide victims
P Rosel et al.
NEUROPSYCHOBIOLOGY (2004)
The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways
MJ Millan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
New selective ligands of human cloned melatonin MT1 and MT2 receptors
V Audinot et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2003)
The neural substrates of affective processing in depressed patients treated with venlafaxine
RJ Davidson et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Combining antidepressants for treatment-resistant depression: A review
RW Lam et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
A polymorphism in the dopamine beta-hydroxylase gene is associated with paranoid ideation in patients with major depression
JG Wood et al.
BIOLOGICAL PSYCHIATRY (2002)
A critical role of a facilitatory presynaptic kainate receptor in mossy fiber LTP
SE Lauri et al.
NEURON (2001)
Current trends in the development of new antidepressants
P Pacher et al.
CURRENT MEDICINAL CHEMISTRY (2001)
Prediction of interindividual variation in drug plasma levels in vivo from individual enzyme kinetic data and physiologically based pharmacokinetic modeling
JJP Bogaards et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2000)
Identification of the kainate receptor subunits underlying modulation of excitatory synaptic transmission in the CA3 region of the hippocampus
A Contractor et al.
JOURNAL OF NEUROSCIENCE (2000)
Hippocampal volume reduction in major depression
JD Bremner et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
分享论文
